Coherus Oncology CHRS
NASDAQ CHRS
$0.99 -0.08 (-7.48%)
At close: Oct 16, 2026 · 4:00 PM EDT

Coherus Oncology (CHRS) Amortization of Deferred Charges (2015 - 2023)

Updated

Analysis

Coherus Oncology (CHRS) Amortization of Deferred Charges (2015 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Coherus Oncology 155.59 Mn -480.55 Mn 10.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 595,000.00
Sep 30, 2023 583,000.00
Jun 30, 2023 573,000.00
Mar 31, 2023 656,000.00
Dec 31, 2022 800,000.00
Sep 30, 2022 954,000.00
Jun 30, 2022 981,000.00
Mar 31, 2022 3.70 Mn
Dec 31, 2021 1.11 Mn
Sep 30, 2021 1.09 Mn
Jun 30, 2021 1.06 Mn
Mar 31, 2021 1.00 Mn
Dec 31, 2020 989,000.00
Sep 30, 2020 969,000.00
Jun 30, 2020 896,000.00
Mar 31, 2020 627,000.00
Dec 31, 2019 613,000.00
Sep 30, 2019 599,000.00
Jun 30, 2019 580,000.00
Mar 31, 2019 547,000.00
API Access

Coherus Oncology Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=CHRS&period=max&api_key=YOUR_API_KEY